scispace - formally typeset
C

Christine M. Freeman

Researcher at University of Michigan

Publications -  78
Citations -  4970

Christine M. Freeman is an academic researcher from University of Michigan. The author has contributed to research in topics: COPD & Lung. The author has an hindex of 28, co-authored 67 publications receiving 3860 citations. Previous affiliations of Christine M. Freeman include Veterans Health Administration & United States Department of Veterans Affairs.

Papers
More filters
Journal ArticleDOI

Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD

TL;DR: The data suggests the existence of a core pulmonary bacterial microbiome that includes Pseudomonas, Streptococcus, Prevotella, Fusobacterium, Haemophilus, Veillonella, and Porphyromonas within the same lung of subjects with advanced COPD.
Journal ArticleDOI

Analysis of the Upper Respiratory Tract Microbiotas as the Source of the Lung and Gastric Microbiotas in Healthy Individuals

TL;DR: Molecular immigration from the oral cavity appears to be the significant source of the lung microbiome during health, but unlike the stomach, the lungs exhibit evidence of selective elimination of Prevotella bacteria derived from the upper airways.
Journal ArticleDOI

Spatial Variation in the Healthy Human Lung Microbiome and the Adapted Island Model of Lung Biogeography

TL;DR: The lung microbiome in health is more influenced by microbial immigration and elimination (the adapted island model) than by the effects of local growth conditions on bacterial reproduction rates, which are more determinant in advanced lung diseases.
Journal ArticleDOI

Bacterial Topography of the Healthy Human Lower Respiratory Tract.

TL;DR: The bacterial topography of the healthy human respiratory tract is defined and ecological evidence that bacteria enter the lungs in health primarily by microaspiration, with potential contribution in some subjects by direct dispersal along contiguous mucosa, is provided.
Journal ArticleDOI

Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort

TL;DR: This longitudinal, prospective analysis of exacerbations in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) cohort identified several novel biomarkers associated with consistent exacerbations, including CT-defined small airway abnormality on CT, lower interleukin-15 concentrations, and higher interleucin-8 concentrations.